CD44+/CD24- Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study

CD44+/CD24- Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study

Abstract Background The conventional standard treatment for ovarian cancer is not very effective, and the disease is fatal for women. Cancer Stem Cells (CSCs) that express CD44+/CD24- can contribute to chemoresistance and a poor prognosis. We seek to investigate the expression of CSCs (CD44+/CD24-)...

Full description

Bibliographic Details
Main Authors: Unedo Hence Markus Sihombing, Andrijono Andrijono, Gatot Purwoto, Supriadi Gandamihardja, Alida R. Harahap, Primariadewi Rustamadji, Aria Kekalih, Retno Widyawati, Dzicky Rifqi Fuady
Format: Article
Language:English
Published: SpringerOpen 2022-10-01
Series:Journal of the Egyptian National Cancer Institute
Subjects:
Ovarian Cancer
CD44+/CD24-
Flow cytometry
Immunohistochemistry
Chemoresistance
Online Access:https://doi.org/10.1186/s43046-022-00143-2

Internet

https://doi.org/10.1186/s43046-022-00143-2

Similar Items